PCNA in Pan-Cancer: A Prognostic Biomarker Unveiled Through a Data-Driven, Multidimensional Analysis of Transcriptomics, Immunity, and Functional Profiling
Saved in:
| Main Authors: | Depanshi Pandit, Ravindranath Bilachi Sanganabasappa, Amardeep Dhillon, Sanjiban Chakrabarty |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-06-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.5c03331 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USP1/UAF1 targets polyubiquitinated PCNA with an exo-cleavage mechanism that can temporarily enrich for monoubiquitinated PCNA
by: Niels Keijzer, et al.
Published: (2025-07-01) -
NUB1 reduction promotes PCNA-mediated tumor growth by disturbing the PCNA polyubiquitination/NEDDylation in hepatocellular carcinoma cells
by: Dongnian Du, et al.
Published: (2025-03-01) -
Integrating bioinformatics with experimental validation unveils immunological and prognostic significance of PVRIG in pan-cancer
by: Peng Ma, et al.
Published: (2025-04-01) -
TCF3 as a multidimensional biomarker: oncogenicity, genomic alterations, and immune landscape in pan-cancer analysis
by: Nie Huiling, et al.
Published: (2024-08-01) -
PGLS as an immune and prognostic biomarker: from pan-cancer analysis to validation
by: Shiqiong Lei, et al.
Published: (2025-07-01)